Kenya is considering a package of fiscal incentives and regulatory reforms to accelerate domestic manufacturing of health commodities, as part of efforts to strengthen supply chains and position itself as a regional production hub.
Senior officials said the strategy aims to scale up local production of essential drugs, vaccines and diagnostic tools, reducing reliance on imports and shielding the country from global supply disruptions linked to conflict and climate change.
The policy direction was outlined during the 26th MEDEXPO International Trade Exhibition in Nairobi, which has brought together industry players from more than 30 countries to showcase medical technologies, pharmaceuticals and laboratory equipment.
Regina Akoth Ombam, principal secretary in the State Department for Trade, said the government is prioritising investment in health technologies and essential commodities as part of its broader industrial transformation agenda.
“Indigenous manufacturing will not only meet domestic demand but also create export opportunities and strengthen economic resilience,” she said.
More Read
Officials noted that recent global shocks — including geopolitical tensions and climate-related disruptions — have exposed vulnerabilities in international supply chains, particularly for critical medical supplies. Kenya’s push for local production is intended to mitigate these risks while improving access to affordable healthcare products.
Ouma Oluga, principal secretary in the State Department for Medical Services, said expanding domestic manufacturing capacity would play a crucial role in addressing the country’s disease burden and supporting economic growth.
“Investments in local production will help stabilise foreign exchange reserves through exports, while ensuring a reliable supply of essential health commodities,” he said.
More Read
The three-day MEDEXPO event features exhibitors from across Africa, Asia and Europe, highlighting innovations in diagnostics, hospital equipment, surgical tools and pharmaceuticals. Chinese firms are among participants showcasing a range of medical products and technologies.
Analysts say Kenya’s ambition to become a continental hub for health manufacturing aligns with wider efforts across Africa to build self-sufficiency in key sectors, particularly after the COVID-19 pandemic exposed heavy dependence on imports for vaccines and medical supplies.
The government is expected to introduce targeted incentives — including tax breaks, streamlined regulatory approvals and support for research and development — to attract both local and foreign investors into the sector.
Officials also emphasised the importance of a skilled workforce and innovation ecosystems to support the growth of the industry, alongside partnerships with global manufacturers and research institutions.
Kenya’s healthcare sector has been identified as a key pillar of socio-economic transformation, with authorities viewing it as both a public health priority and an industrial opportunity.
However, experts caution that scaling up domestic production will require sustained investment in infrastructure, regulatory capacity and quality assurance systems to meet international standards and compete in export markets.
More Read
The initiative is also expected to complement regional efforts under the African Continental Free Trade Area (AfCFTA), which aims to boost intra-African trade and industrial development.
As the exhibition continues through Friday, policymakers and industry stakeholders are expected to explore concrete partnerships and investment opportunities to advance Kenya’s vision of becoming a leading producer of health commodities in Africa.
